Matthew A. Spear

Chief Medical Officer, Poseida Therapeutics, Inc.

Companies

Poseida Therapeutics, Inc.Chief Medical Officer Jul 9, 2020 to Mar 1, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Poseida Therapeutics, Inc.111,485 shares²Mar 1, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 1, 2022Granted 50,000 shares of Poseida Therapeutics, Inc.²
Dec 6, 2021Exercised options 10,000 shares at $1.32 of Poseida Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARPoseida Therapeutics, Inc., Chief Medical Officer
2
SEC EDGARPoseida Therapeutics, Inc. shares after the filing of Mar 1, 2022
3
SEC EDGARForm 4 filed Dec 8, 2021